EHI
Eagle Health Investments Portfolio holdings
AUM
$405M
This Quarter Return
+1.32%
1 Year Return
+14.19%
3 Year Return
+134.25%
5 Year Return
–
10 Year Return
–
AUM
$246M
AUM Growth
+$246M
(+58%)
Cap. Flow
+$87.9M
Cap. Flow
% of AUM
35.67%
Top 10 Holdings %
Top 10 Hldgs %
67.32%
Holding
27
New
3
Increased
17
Reduced
2
Closed
3
Top Buys
| 1 |
Agios Pharmaceuticals
AGIO
|
$14.7M |
| 2 |
Natera
NTRA
|
$9.12M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$7.83M |
| 4 |
Inspire Medical Systems
INSP
|
$7.75M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$6.91M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$6.71M |
| 2 |
Illumina
ILMN
|
$5.81M |
| 3 |
Butterfly Network
BFLY
|
$2.26M |
| 4 |
Thermo Fisher Scientific
TMO
|
$1.78M |
| 5 |
Guardant Health
GH
|
$641K |
Sector Composition
| 1 | Healthcare | 98.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
IQVIA
IQV
$31.4B
| $19.3M | 7.59% |
100,177
+27,800
| +38% | +$5.37M |
|
|
2
Vertex Pharmaceuticals
VRTX
$103B
| $19M | 7.46% |
88,444
+36,444
| +70% | +$7.83M |
|
3
Humana
HUM
$37.1B
| $18.8M | 7.39% |
44,921
+13,759
| +44% | +$5.77M |
|
|
4
Agios Pharmaceuticals
AGIO
$2.24B
| $18.3M | 7.19% |
354,650
+284,950
| +409% | +$14.7M |
|
5
AstraZeneca
AZN
$248B
| $17.7M | 6.96% |
356,789
+126,689
| +55% | +$6.3M |
|
|
6
Natera
NTRA
$23B
| $17.1M | 6.71% |
168,394
+89,794
| +114% | +$9.12M |
|
7
United Therapeutics
UTHR
$18.5B
| $15.6M | 6.11% |
93,100
+23,100
| +33% | +$3.86M |
|
8
Alnylam Pharmaceuticals
ALNY
$59.3B
| $15.3M | 6% |
108,179
+22,386
| +26% | +$3.16M |
|
|
BPMC
9
DELISTED
Blueprint Medicines
BPMC
| $12.9M | 5.08% |
133,163
+71,103
| +115% | +$6.91M |
|
10
argenx
ARGX
$42.7B
| $11.7M | 4.61% |
42,632
+23,045
| +118% | +$6.35M |
|
|
AXNX
11
DELISTED
Axonics, Inc. Common Stock
AXNX
| $11.7M | 4.58% |
194,965
+12,125
| +7% | +$726K |
|
|
12
Thermo Fisher Scientific
TMO
$183B
| $9.56M | 3.75% |
20,951
-3,900
| -16% | -$1.78M |
|
13
Adaptive Biotechnologies
ADPT
$1.95B
| $8.14M | 3.2% |
202,220
+118,685
| +142% | +$4.78M |
|
|
14
Inspire Medical Systems
INSP
$2.77B
| $7.75M | 3.04% |
+37,453
| New | +$7.75M |
|
|
CANO
15
DELISTED
Cano Health, Inc.
CANO
| $6.57M | 2.58% |
496,100
+307,800
| +163% | +$4.08M |
|
|
MRTX
16
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $6.24M | 2.45% |
+36,400
| New | +$6.24M |
|
17
Outset Medical
OM
$243M
| $5.29M | 2.08% |
97,300
+25,300
| +35% | +$1.38M |
|
18
DexCom
DXCM
$29.1B
| $4.96M | 1.95% |
13,800
| – | – |
|
|
19
Guardant Health
GH
$8.31B
| $4.31M | 1.69% |
28,260
-4,200
| -13% | -$641K |
|
20
Seer Inc
SEER
$115M
| $4.18M | 1.64% |
83,500
+63,500
| +318% | +$3.18M |
|
|
CMAX
21
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $4.12M | 1.62% |
340,075
+313,067
| +1,159% | +$3.79M |
|
|
DRNA
22
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $4.12M | 1.62% |
161,125
+92,125
| +134% | +$2.36M |
|
23
4D Molecular Therapeutics
FDMT
$288M
| $2.17M | 0.85% |
50,000
| – | – |
|
|
OLK
24
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $1.44M | 0.57% |
+40,000
| New | +$1.44M |
|
|
25
Butterfly Network
BFLY
$388M
| – | – |
-114,100
| Closed | -$2.26M |
|